Hospital transfer after a breast cancer diagnosis
العنوان: | Hospital transfer after a breast cancer diagnosis |
---|---|
المؤلفون: | Heeg, E., Schreuder, K., Spronk, P.E.R., Oosterwijk, J.C., Marang-van de Mheen, P.J., Siesling, S., Peeters, M.T.F.D.V., NABON Breast Canc Audit |
المساهمون: | Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), Health Technology & Services Research |
المصدر: | EJSO-European Journal of Surgical Oncology, 45(4), 560-566. ELSEVIER SCI LTD EJSO, 45(4), 560-566. ELSEVIER SCI LTD European journal of surgical oncology, 45(4), 560-566. Elsevier |
سنة النشر: | 2019 |
مصطلحات موضوعية: | medicine.medical_treatment, Mammaplasty, CONTINUITY, DELAYS, Mastectomy, Segmental, 0302 clinical medicine, Breast cancer, 030212 general & internal medicine, Registries, Netherlands, Aged, 80 and over, OUTCOMES, Age Factors, Treatment delay, ASSOCIATION, General Medicine, Middle Aged, Neoadjuvant Therapy, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, FRAGMENTATION, Mastectomy, Adult, Patient Transfer, medicine.medical_specialty, Time to treatment, Breast Neoplasms, Time-to-Treatment, 03 medical and health sciences, Internal medicine, MASTECTOMY, medicine, QUALITY, Humans, RECONSTRUCTION, Hospital transfer, Aged, Chemotherapy, business.industry, 22/3 OA procedure, CARE, medicine.disease, Discontinue of care, Cancer registry, Population based study, Propensity score matching, Surgery, business |
الوصف: | PURPOSE:Patients may transfer of hospital for clinical reasons but this may delay time to treatment. The purpose ofthis study is to provide insight in the extent of hospital transfer in breast cancer care; which type of patients transfer and what is the impact on time to treatment.METHODS:We included 41,413 breast cancer patients registered in the Netherlands Cancer Registry between 2014and 2016. We investigated transfer of hospital between diagnosis and first treatment being surgery or neoadjuvant chemotherapy (NAC). Co-variate adjusted characteristics predictive for hospital transfer were determined. To adjust for possible treatment by indication bias we used propensity score matching (PSM). Time to treatment in patients with and without hospital transfer was compared.RESULTS:Among 41,413 patients, 8.5% of all patients transferred to another hospital between diagnosis and firsttreatment; 4.9% before primary surgery and 24.8% before NAC. Especially young (aged CONCLUSIONS:While almost 5% of Dutch patients treated with primary surgery transfer hospital after diagnosis andup to 25% for patients treated with NAC, our findings suggest that especially those treated with primary surgery are at risk for additional treatment delay by hospital transfer. |
وصف الملف: | application/pdf |
اللغة: | English |
تدمد: | 0748-7983 |
DOI: | 10.1016/j.ejso.2018.12.017 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb11cd71a3902e6a272b28f1fb8208a7 https://doi.org/10.1016/j.ejso.2018.12.017 |
Rights: | OPEN |
رقم الانضمام: | edsair.doi.dedup.....bb11cd71a3902e6a272b28f1fb8208a7 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 07487983 |
---|---|
DOI: | 10.1016/j.ejso.2018.12.017 |